Table 1. Overview on the most important characteristics of the three mAbs against NheA applied in the present study.
mAb | Ig subtype | sensitivity rNheA# | Inhibitions of antibody reactivity by soluble antigen | Titer* in indirect EIA (strain no.) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
MHI163 | MHI165 | MHI241 | DSM31 | NVH 1280/33 | ||||||
1G4 | IgG2a | 107 ng ml-1 | 63% | 1:103 (± 12) | 1:30 (± 10) | 1:39 (± 5) | 1:98 (± 13) | 1:94 (± 17) | ||
1A8 | IgG1 | negative | negativ | 1:760 (± 13) | 1:870 (± 1) | 1:861 (± 3) | 1:631 (± 15) | 1:974 (± 3) | ||
2G11 | IgG2a | 98 ng ml-1 | 42% | 1:10 (± 3) | 1:7 (± 5) | 1:15 (± 10) | n. a | n. a |
# sensitivity defined as the concentration of rNheA resulting in an OD450 of 0.3 under the conditions of an indirect EIA; values in brackets indicate the variation coefficient in %.
n. a. not analyzed
* dilution resulting in an OD450 of 1.0